Across TCGA pan-cancer cohorts, LINC02796 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated LINC02796 data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC02796 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02796 expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.
BLCA, KIRP, and GBM are the cancer types where LINC02796 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.